| Stage | CMG | % of rev | CMI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.3B | 100.00% | $9.4B | 100.00% | CMI ×2.87 |
| Gross profit | $768M | 23.33% | $2.6B | 27.71% | CMI +4.4pp |
| Operating income | $452M | 13.72% | $1.3B | 13.95% | CMI +0.2pp |
| Pre-tax income | $457M | 13.88% | $1.4B | 15.05% | CMI +1.2pp |
| Net income | $340M | 10.32% | $1.2B | 12.39% | CMI +2.1pp |
| Stage | CMG | CMI | Gap · A − B |
|---|---|---|---|
| Revenue | $3.3B100.00% | $9.4B100.00% | CMI ×2.87 |
| Gross profit | 23.33%$768M | 27.71%$2.6B | CMI +4.4pp |
| Operating income | 13.72%$452M | 13.95%$1.3B | CMI +0.2pp |
| Pre-tax income | 13.88%$457M | 15.05%$1.4B | CMI +1.2pp |
| Net income |
| 10.32%$340M |
| 12.39%$1.2B |
| CMI +2.1pp |
No shared counterparties.